当前位置:
X-MOL 学术
›
Org. Process Res. Dev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Development of a Scalable Synthesis of Gastrazole (JB95008): A Potent CCK2 Receptor Antagonist
Organic Process Research & Development ( IF 3.1 ) Pub Date : June 24, 2005 , DOI: 10.1021/op0500638 Dominic Ormerod 1 , Bert Willemsens 1 , Rit Mermans 1 , Jaak Langens 1 , Guy Winderickx 1 , S. Barret Kalindjian 1 , Ildiko M. Buck 1 , Iain M. McDonald 1
Organic Process Research & Development ( IF 3.1 ) Pub Date : June 24, 2005 , DOI: 10.1021/op0500638 Dominic Ormerod 1 , Bert Willemsens 1 , Rit Mermans 1 , Jaak Langens 1 , Guy Winderickx 1 , S. Barret Kalindjian 1 , Ildiko M. Buck 1 , Iain M. McDonald 1
Affiliation
A practical and scalable synthesis was developed that was used to prepare multikilogram batches of gastrazole, a selective cholecystokinin-2 receptor antagonist. In addition, evidence was found to indicate an amide bond-forming reaction proceeded via the isoimide of a benzimidazoleamide acid derivative.
中文翻译:
Gastrazole(JB95008)的可扩展合成的开发:强大的CC K 2受体拮抗剂。
开发了一种实用且可扩展的合成方法,该合成方法可用于制备多公斤级的加他唑,一种选择性的胆囊收缩素2受体拮抗剂。另外,发现证据表明通过苯并咪唑酰胺酸衍生物的异酰亚胺进行了形成酰胺键的反应。
更新日期:2017-01-31
中文翻译:
Gastrazole(JB95008)的可扩展合成的开发:强大的CC K 2受体拮抗剂。
开发了一种实用且可扩展的合成方法,该合成方法可用于制备多公斤级的加他唑,一种选择性的胆囊收缩素2受体拮抗剂。另外,发现证据表明通过苯并咪唑酰胺酸衍生物的异酰亚胺进行了形成酰胺键的反应。